术前蛋白尿严重程度是肾切除术患者总体死亡的风险因素
研究基于1995至2010年间接受根治性或部分性肾切除术的1846例局限性透明细胞肾细胞癌患者,按术前蛋白尿严重程度分组,评估其与总体生存和癌症特异性生存的关系。多因素分析显示,以轻度蛋白尿为参照,重度蛋白尿与总体死亡风险升高相关(HR 1.61,95%CI 1.26-2.07,P<0.001),但蛋白尿水平与癌症特异性生存无关。
要点
- 术前蛋白尿检测可用者1347例(73%),其中轻度804例(60%)、中度332例(25%)、重度211例(16%)。
- 以轻度蛋白尿为参照,中度蛋白尿全因死亡调整HR 1.18(95%CI 0.95-1.48,P=0.14),重度蛋白尿调整HR 1.61(95%CI 1.26-2.07,P<0.001)。
- 蛋白尿水平与癌症特异性生存无关。
核心结论
- 重度术前蛋白尿与接受根治性或部分性肾切除术的局限性透明细胞肾细胞癌患者较差的总体生存相关。
- 术前蛋白尿应在肾切除术患者中评估,并在估计患者总体健康状况时加以考虑。
研究设计与样本
- 利用本机构肾切除术登记数据库,识别1995至2010年间接受根治性或部分性肾切除术的1846例局限性透明细胞肾细胞癌患者。
- 按术前蛋白尿严重程度(轻度、中度、重度)分组分析,采用Kaplan-Meier法估计总体生存和癌症特异性生存,采用Cox比例风险回归模型评估与总体死亡和癌症特异性死亡相关的变量。
主要发现
- 共有1347例(73%)患者有术前尿蛋白检测结果。
- 804例(60%)被分类为轻度蛋白尿(每日小于150 mg),332例(25%)为中度蛋白尿(每日150至500 mg),211例(16%)为重度蛋白尿(每日大于500 mg)。
- 以轻度蛋白尿为参照,中度蛋白尿的全因死亡调整HR为1.18(95%CI 0.95-1.48,P=0.14),重度蛋白尿的全因死亡调整HR为1.61(95%CI 1.26-2.07,P<0.001)。
- 蛋白尿水平与癌症特异性生存无关。
临床怎么用
- 术前蛋白尿应在接受肾切除术的患者中评估,并在估计患者总体健康状况时加以考虑。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Chronic kidney disease may adversely affect survival following nephrectomy. Proteinuria is increasingly used as a marker of kidney disease. However, the relationship between preoperative proteinuria and survival after nephrectomy remains incompletely characterized. We evaluated the association of preoperative proteinuria with overall and cancer specific survival using our institutional nephrectomy registry. MATERIALS AND METHODS: We identified 1,846 patients with localized clear cell renal cell carcinoma treated with curative intent (radical or partial nephrectomy) between 1995 and 2010. Patients were categorized for analysis based on preoperative proteinuria severity (mild, moderate or severe). Overall and cancer specific survival was estimated by the Kaplan-Meier method. Cox proportional hazards regression models were used to assess for variables associated with overall and cancer specific mortality. RESULTS: Preoperative urine protein testing was available in 1,347 patients (73%). A total of 804 patients (60%) were classified with mild proteinuria (less than 150 mg per day), 332 (25%) were classified with moderate proteinuria (150 to 500 mg per day) and 211 (16%) were classified with severe proteinuria (greater than 500 mg per day). On multivariable analysis with mild proteinuria as the reference category the adjusted HR for all cause mortality was 1.18 (95% CI 0.95-1.48, p = 0.14) for moderate proteinuria and 1.61 (95% CI 1.26-2.07, p <0.001) for severe proteinuria. However, the proteinuria level was not associated with cancer specific survival. CONCLUSIONS: Severe preoperative proteinuria is associated with worse overall survival following radical or partial nephrectomy for localized clear cell renal cell carcinoma. Preoperative proteinuria should be evaluated in patients undergoing nephrectomy and considered when estimating overall patient health status.
引用
- Yang DY, Thompson RH, Zaid HB, et al. Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy. J Urol. 2017. PMID: 28396181. doi:10.1016/j.juro.2017.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。